These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 35426293)
1. [Application of tetrahedral framework nucleic acids in the treatment of osteoarthritis]. Li S; Si H; Shen B Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2022 Apr; 36(4):505-510. PubMed ID: 35426293 [TBL] [Abstract][Full Text] [Related]
2. Tetrahedral Framework Nucleic Acid Inhibits Chondrocyte Apoptosis and Oxidative Stress through Activation of Autophagy. Shi S; Tian T; Li Y; Xiao D; Zhang T; Gong P; Lin Y ACS Appl Mater Interfaces; 2020 Dec; 12(51):56782-56791. PubMed ID: 33289541 [TBL] [Abstract][Full Text] [Related]
3. A Novel Bioswitchable miRNA Mimic Delivery System: Therapeutic Strategies Upgraded from Tetrahedral Framework Nucleic Acid System for Fibrotic Disease Treatment and Pyroptosis Pathway Inhibition. Jiang Y; Li S; Shi R; Yin W; Lv W; Tian T; Lin Y Adv Sci (Weinh); 2024 Jan; 11(1):e2305622. PubMed ID: 37984862 [TBL] [Abstract][Full Text] [Related]
4. Tetrahedral Framework Nucleic Acid-Based Delivery of Astaxanthin Suppresses Chondrocyte Pyroptosis and Modulates Oxidative Stress for the Treatment of Osteoarthritis. Li Y; Li J; Xu S; Li D; Zhang Z; Huang Q; Wang X; Shen M; Xu S Adv Healthc Mater; 2024 Nov; 13(28):e2401452. PubMed ID: 38923865 [TBL] [Abstract][Full Text] [Related]
5. The immune regulatory effects of tetrahedral framework nucleic acid on human T cells via the mitogen-activated protein kinase pathway. Liu X; Yu Z; Wu Y; Shi S; Yao J; Feng X; Wen D; Shi Z; Zhao Z; Li Y; Zhou H; You C; Lin Y; Yang M Cell Prolif; 2021 Aug; 54(8):e13084. PubMed ID: 34170049 [TBL] [Abstract][Full Text] [Related]
6. Tetrahedral framework nucleic acid carrying angiogenic peptide prevents bisphosphonate-related osteonecrosis of the jaw by promoting angiogenesis. Zhao D; Xiao D; Liu M; Li J; Peng S; He Q; Sun Y; Xiao J; Lin Y Int J Oral Sci; 2022 Apr; 14(1):23. PubMed ID: 35477924 [TBL] [Abstract][Full Text] [Related]
7. Nucleic Acid Nanomaterials-based Therapy for Osteoarthritis: Progress and Prospects. Yao Y; Yang M; Shi S Curr Drug Metab; 2023; 24(5):338-352. PubMed ID: 36733192 [TBL] [Abstract][Full Text] [Related]
8. Progress in Biomedical Applications of Tetrahedral Framework Nucleic Acid-Based Functional Systems. Zhang T; Cui W; Tian T; Shi S; Lin Y ACS Appl Mater Interfaces; 2020 Oct; 12(42):47115-47126. PubMed ID: 32975109 [TBL] [Abstract][Full Text] [Related]
9. Angiogenic Aptamer-Modified Tetrahedral Framework Nucleic Acid Promotes Angiogenesis In Vitro and In Vivo. Zhao D; Liu M; Li J; Xiao D; Peng S; He Q; Sun Y; Li Q; Lin Y ACS Appl Mater Interfaces; 2021 Jun; 13(25):29439-29449. PubMed ID: 34137587 [TBL] [Abstract][Full Text] [Related]
10. Liver-Targeted Delivery of Small Interfering RNA of C-C Chemokine Receptor 2 with Tetrahedral Framework Nucleic Acid Attenuates Liver Cirrhosis. Tian T; Zhao C; Li S; Huang Z; Guo Y; Dai W; Bai R; Tang C; Lin Y; Gao J ACS Appl Mater Interfaces; 2023 Mar; 15(8):10492-10505. PubMed ID: 36799737 [TBL] [Abstract][Full Text] [Related]
11. Tetrahedral Framework Nucleic Acids Reverse New-Onset Type 1 Diabetes. Gao S; Zhou M; Li Y; Xiao D; Wang Y; Yao Y; Gao Y; Cai X; Lin Y ACS Appl Mater Interfaces; 2021 Nov; 13(43):50802-50811. PubMed ID: 34665600 [TBL] [Abstract][Full Text] [Related]
12. MiR-29a and MiR-140 Protect Chondrocytes against the Anti-Proliferation and Cell Matrix Signaling Changes by IL-1β. Li X; Zhen Z; Tang G; Zheng C; Yang G Mol Cells; 2016 Feb; 39(2):103-10. PubMed ID: 26608362 [TBL] [Abstract][Full Text] [Related]
13. Enhanced Penetrability of a Tetrahedral Framework Nucleic Acid by Modification with iRGD for DOX-Targeted Delivery to Triple-Negative Breast Cancer. Liu M; Ma W; Zhao D; Li J; Li Q; Liu Y; Hao L; Lin Y ACS Appl Mater Interfaces; 2021 Jun; 13(22):25825-25835. PubMed ID: 34038071 [TBL] [Abstract][Full Text] [Related]
14. Functionalizing Framework Nucleic-Acid-Based Nanostructures for Biomedical Application. Zhang T; Tian T; Lin Y Adv Mater; 2022 Nov; 34(46):e2107820. PubMed ID: 34787933 [TBL] [Abstract][Full Text] [Related]
15. A Complex Relationship between Visfatin and Resistin and microRNA: An In Vitro Study on Human Chondrocyte Cultures. Cheleschi S; Giordano N; Volpi N; Tenti S; Gallo I; Di Meglio M; Giannotti S; Fioravanti A Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563239 [TBL] [Abstract][Full Text] [Related]
16. Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes. Díaz-Prado S; Cicione C; Muiños-López E; Hermida-Gómez T; Oreiro N; Fernández-López C; Blanco FJ BMC Musculoskelet Disord; 2012 Aug; 13():144. PubMed ID: 22883423 [TBL] [Abstract][Full Text] [Related]
17. 4cRNA NEAT1 Sponge Adsorption of miR-378 Modulates Activity of Lipopolysaccharide-treated Articular Chondrocytes and Influences the Pathological Development of Osteoarthritis. Wang X; Hu Y; Fang C; Zhu C Altern Ther Health Med; 2022 Sep; 28(6):103-111. PubMed ID: 35687708 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-320c inhibits development of osteoarthritis through downregulation of canonical Wnt signaling pathway. Hu S; Mao G; Zhang Z; Wu P; Wen X; Liao W; Zhang Z Life Sci; 2019 Jul; 228():242-250. PubMed ID: 31075235 [TBL] [Abstract][Full Text] [Related]
19. Tetrahedral framework nucleic acid loaded with glabridin: A transdermal delivery system applicated to anti-hyperpigmentation. He J; Chen W; Chen X; Xie Y; Zhao Y; Tian T; Guo B; Cai X Cell Prolif; 2023 Dec; 56(12):e13495. PubMed ID: 37132449 [TBL] [Abstract][Full Text] [Related]
20. Unleashing Novel Therapeutic Strategies for Dry Eye: Targeting ROS and the cGAS-STING Signaling Pathway with Tetrahedral Framework Nucleic Acids. Yan D; Huang C; Ouyang W; Hu J; Liu Z Adv Healthc Mater; 2024 Dec; 13(30):e2400198. PubMed ID: 39073031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]